You have 9 free searches left this month | for more free features.

Acute Myelocytic Leukemia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myelocytic Leukemia Trial in Hefei (Unrelated umbilical cord blood, Venetoclax, Decetabine)

Recruiting
  • Acute Myelocytic Leukemia
  • Unrelated umbilical cord blood
  • +3 more
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Oct 27, 2023

Acute Myelocytic Leukemia, Myelodysplastic Syndrome Trial in Germany (Azacitidine)

Completed
  • Acute Myelocytic Leukemia
  • Myelodysplastic Syndrome
  • Berlin, Germany
  • +10 more
Nov 12, 2021

MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Hackensack, New Jersey
  • +6 more
Nov 18, 2022

Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 7, 2021

Acute Myeloid Leukemia Trial in Hangzhou (RC1012 injection (allo-DNT cells))

Recruiting
  • Acute Myeloid Leukemia
  • RC1012 injection (allo-DNT cells)
  • Hangzhou, Zhejiang, China
    First Affiliated Hospital of Zhejiang University
Aug 3, 2022

Leukemia, Myelocytic, Acute Trial in United States (CD34+ selection with CliniMACS device)

Completed
  • Leukemia, Myelocytic, Acute
  • CD34+ selection with CliniMACS device
  • Duarte, California
  • +7 more
Oct 21, 2021

Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (HSC835)

Completed
  • Acute Myelocytic Leukemia
  • +12 more
  • HSC835
  • Minneapolis, Minnesota
    Novartis Investigative Site
Dec 9, 2020

Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial in Belgium (Mesenchymal stem

Terminated
  • Leukemia, Myeloid, Acute
  • +8 more
  • Mesenchymal stem cells
  • Isotonic solution
  • Edeghem, Antwerpen, Belgium
  • +9 more
Aug 31, 2021

Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial run by the NHLBI (Miltenyi

Completed
  • Leukemia, Myeloid, Acute
  • +2 more
  • Miltenyi Magnetic cell sorter for CD3
  • Bethesda, Maryland
    National Institutes of Health
Oct 7, 2020

Leukemia, Myelocytic, Acute Trial in Czechia, Germany (study part 1 - dose daunorubicin, induction cycles)

Recruiting
  • Leukemia, Myelocytic, Acute
  • study part 1 - dose daunorubicin
  • induction cycles
  • Brno, Czechia
  • +39 more
Sep 6, 2021

Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,

Terminated
  • Double Cord Blood Transplant
  • +8 more
  • TXA127 300 mcg/kg/day
  • TXA127 1000 mcg/kg/day
  • Houston, Texas
    MD Anderson Cancer Center
Dec 7, 2020

Acute Myeloid Leukemia Trial in Antalya

Recruiting
  • Acute Myeloid Leukemia
    • Antalya, Turkey
      Antalya Training and Research Hospital
    Jul 29, 2023

    Acute Myeloid Leukemia Trial (Dasatinib)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 20, 2023

    Patients With Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia, Adult
      • Freiburg, CA, Germany
        Medical Center- University of Freiburg
      Aug 4, 2023

      Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

      Recruiting
      • Acute Myeloid Leukemia Refractory
      • Acute Myeloid Leukemia, in Relapse
      • anti Tim-3/CD123 CAR-T cell therapy
      • Xuzhou, Jiangsu, China
        Kailin Xu
      Nov 4, 2023

      The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding

      Completed
      • Leukemia, Acute
        • (no location specified)
        Jul 23, 2023

        Frequency and Risk Factors of Acute Myeloid Leukemia

        Not yet recruiting
        • Myeloid Leukemia
        • Bone marrow aspirite for diagnosis
        • (no location specified)
        Mar 15, 2023

        Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

        Recruiting
        • Acute Myeloid Leukemia
        • +3 more
        • CD123 targeted CAR-NK cells
        • Taiyuan, Shanxi, China
          Shanxi Bethune Hospital
        Aug 28, 2023

        AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

        Not yet recruiting
        • AML
        • +11 more
        • (no location specified)
        Aug 14, 2023

        H19 in Acute Lymphoblastic Leukemia.

        Not yet recruiting
        • Acute Lymphoid Leukemia
          • (no location specified)
          Jul 11, 2023

          Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

          Recruiting
          • Acute Myeloid Leukemia
          • Beijing, Beijing, China
            Peking University People's Hospital
          Jun 23, 2023

          Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

          Active, not recruiting
          • Relapsed Adult ALL
          • Relapsed Adult AML
          • Changchun, Jilin, China
            First Hospital of Jilin University
          Nov 19, 2023

          Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

          Recruiting
          • Acute Myeloid Leukemia Refractory
          • Lyon, France
            Centre Léon Bérard
          Nov 30, 2023

          Acute Myeloid Leukemia Trial (ABBV-787)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • (no location specified)
          Sep 29, 2023

          Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Mitoxantrone hydrochloride liposome injection
          • +3 more
          • (no location specified)
          May 29, 2023